ENOXAPARIN SODIUM | A077857 | SANDOZ INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Kasowitz Benson Torres LLP on behalf of Adventapharma D... FDA-2024-P-0521 · 5 docket documents Adventapharma DWC LLC, represented by Kasowitz Benson Torres LLP, filed this citizen petition requesting that the FDA investigate and take appropriate enforcement actions against Sandoz's generic enoxaparin sodium injection supplied as graduated pre-filled syringes under ANDA number 077857, manufact | 505(q) | 2024-01-26 | Open | Adventapharma DWC LLC |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$11.81
per ml
Lowest NADAC/Unit
$7.13
per ml
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00781329868ENOXAPARIN 120 MG/0.8 ML SYR | $11.81 | ML | Generic | — | 2026-06-17 |
| 00781329969ENOXAPARIN 150 MG/ML SYRINGE | $10.63 | ML | Generic | — | 2026-06-17 |
| 00781323863ENOXAPARIN 30 MG/0.3 ML SYR | $9.62 | ML | Generic | — | 2026-06-17 |
| 00781324664ENOXAPARIN 40 MG/0.4 ML SYR | $8.06 | ML | Generic | — | 2026-06-17 |
| 00781325666ENOXAPARIN 60 MG/0.6 ML SYR | $7.84 | ML | Generic | — | 2026-06-17 |
| 00781326869ENOXAPARIN 100 MG/ML SYRINGE | $7.37 | ML | Generic | — | 2026-06-17 |
| 00781326268ENOXAPARIN 80 MG/0.8 ML SYR | $7.13 | ML | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.